BGI Genomics Co.,Ltd. (SZSE: 300676) has disclosed a plan to repurchase a portion of its issued A-shares using its own funds and raised capital through centralized bidding.
The total amount allocated for the share repurchase is set to be no less than 2.5 billion yuan and no more than 5 billion yuan.
The maximum price for the repurchased shares is capped at 50 yuan per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments